Repurposing of FDA-approved drugs as dual-acting MAO-B and AChE inhibitors against Alzheimer's disease: An in silico and in vitro study. Alzforum, 28 Apr 2023 Mateev E, Kondeva-Burdina M, Georgieva M, Zlatkov A. J Mol Graph Model. 2023 Apr 14;122:108471.